We are in such an interesting position at the moment. Fully funded P3 with results less than 12 months away. Orphan designation in 4 conditions including 3 with planned P2 trials using NNZ-2591 to commence in 2021. Very attractive position that im sure many have taken notice of.
Ann: Positive opinion for all 3 Orphan applications in Europe, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
0.245(1.91%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $5.103M | 389.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 523 | $13.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.10 | 426 | 10 |
View Market Depth
| Last trade - 13.51pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |